Predictable, Safe And Business Aware: UK Medtech's Regulatory Wishlist

UK medtech stakeholders face a year of regulatory decision making on MMD Act secondary legislation and the UKCA marking

A public consultation on the UKCA marking for medtech products is anticipated later in the year. Medtech industry representatives are part of the UK regulator’s advisory team.

alexmillos

UK health care stakeholders are on a mission to integrate best practice and good governance into the system of medtech regulation that is replacing long-standing EU regulatory oversight in the post-Brexit era.

The first stage was the passage in February of the Medicines and Medical Devices (MMD) Act 2021. Developing the all-important...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from United Kingdom

More from Europe